Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
17%(1 trials)

Phase Distribution

Ph not_applicable
2
29%
Ph phase_4
2
29%
Ph phase_2
2
29%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
Phase 4Post-market surveillance
2(33.3%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(6)
Other(1)

Detailed Status

Completed6
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (33.3%)
Phase 42 (33.3%)
N/A2 (33.3%)

Trials by Status

unknown114%
completed686%

Recent Activity

0 active trials
Showing 5 of 7
completednot_applicable

Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System

NCT01788150
completedphase_2

Ticagrelor And PrEconditioning in Patients With coronaRy Artery diSease

NCT02701140
completednot_applicable

"TransRadial Ultra Support Technique" (TRUST)

NCT03025685
completed

PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study

NCT01148329
completedphase_4

Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study

NCT01700322
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT01788150Not Applicable

Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System

Completed
NCT02701140Phase 2

Ticagrelor And PrEconditioning in Patients With coronaRy Artery diSease

Completed
NCT03025685Not Applicable

"TransRadial Ultra Support Technique" (TRUST)

Completed
NCT01148329

PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study

Completed
NCT01700322Phase 4

Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study

Completed
NCT00967902Phase 2

Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent

Completed
NCT00484965Phase 4

Erythrocyte-Mediated Drug Delivery for the Prevention of Stent Restenosis

Unknown

All 7 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
7